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The heart and hypothyroidism
J.M.BENNETT, A.F.STEYN
Summary
The association of hypothyroidism with heart
disease is reviewed. The. relative raritY" of cardiac
failure due to hypothyroidism is stressed, and
structural abnormalities of the heart due to
hypothyroidism are discussed. The clinical
management of hypothyroid patients with heart
disease is described.
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Hypothyroidism may initiate cardiac disease or worsen that
which alread\' exists. Treatmenr of the cardiac problem is
influenced by the thyroid disorder and vice versa. We recenrly
saw a patienr with hypothyroidism who presenred with
cardiomyopathy and severe hean failure resistanr to treatment
with digitalis and diuretics. This c~se focused our attention on
the problems of management of hypothyroidism complicated by
hean disease. The clinical presentation and management ofsuch
patients are re\·iewed.
Myocardial function
Graettinger el al. I have found that resting cardiac output is
reduced in hypothyroid patients but that cardiac output, stroke
volume and pulse rate increase normally during exercise. This
finding implies that cardiac function is still normal, i.e. with the
reduction in oxygen requiremenrs and metabolism there is a
parallel reduction in cardiac function. It is generally accepted
that cardiac function in hypothyroid patients is in keeping with
their. metabolic requirements. Treatment with thyroxine reduces
myocardial size to normal,2.3 a process which may take from 3
weeks to ID monrhs. Even when the hean is functionally normal, .
histological changes in the cardiac muscle have been reponed.
The prognostic implications of these changes are not quite clear.
The heart may be dilated and hypenrophied when the patient
is first seen.2 Hypothyroid patients often have symptoms
compatible with those of heart failure such as tiredness,
dyspnoea and even orthopnoea. Clinical signs of hypothyroidism
which may be confused with heart failure include oedema,
ascites, cardiomegaly and pleural effusions. Since
hypothyroidism is a rare cause of heart failure other causes of
heart failure must be excluded in such patients.2.3 According to
De Groot' heart failure occurs more commonly in older patients,
in whom other factors causing heart disease are more common.
Hypothyroidism has been listed as a cause of hypertension, but a
recent study showed that hypothyroidism does not accelerate the
development of hypertension.'1 In our experience cardiac failure
due to hypothyroidism per se is rare. W/e have seen only I such a
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patient, a young girl in whom no other factors could have caused
the heart failure. She responded poorly to conventional
treatment with digitalis and diuretics. A vasodilator improved
her exercise capacity, but it remained limited. Other patients
with initial cardiomegaly all improved with thyroxine
replacement therapy only.
Santos el al.; recently described the echocardiographic
findings of asymmetrical septal hypertrophy (ASH) in patients
with hypothyroidism. Septal thickening was present in 17 of 19
patients. In 10 patients who were re-investigated the thickness of
the septum returned to normal after thyroxine therapy. The
manner in which septal thickening is caused in hypothyroidism
is still unknown. What is important is that this is one form of
heart disease which can be cured when diagnosed and treated
appropriately. We have seen no signs of this condition in 7
consecutive patients with hypothyroidism seen in our clinic. It is
known that patients with ASH can present with svmptoms of
angina pectoris and that in some patients with hypothyroidism
the angina improves with hormone substitution therapy., It is
interesting to speculate that this group of patients might perhaps
have had ASH which improved on therapy.
Pericardial effusion
Dilation of the heart and pericardial effusion are known causes of
radiological cardiomegaly. Kerber and Sherman6 found
echocardiographic evidence of pericardial effusion in 10 of 33
patients with hypothyroidism. Only 7 of the 10 had
cardiomegaly. No patient had cardiac tamponade, this being a
rare finding in hypothyroidism. We have seen I patient with
signs of cardiac tamponade and echocardiographic features of a
large pericardial effusion. After aspiration of 2, 9 litres of straw-
coloured pericardial fluid the patient's condition improved
dramatically. The fact that it probably takes a long time for the
effusion to develop explains the rarity of tamponade in these
patients. Pericardial effusions usually disappear after treatment.
The fluid usually has a high chol~steroland protein content and
is sometimes described as resembling 'gold paint'.
Ischaemic heart disease
The association of ischaemic heart disease and hypothyroidism is
controversial 7 .8 However, hypothyroidism is menrioned as a risk
factor for ischaemic heart disease. A raised serum cholesterol
level and other lipid abnormalities are known to occur in patienrs
with hypothyroidism. Agdeppa er al. 9 found that high-density
lipoprotein cholesterol (HDL-C) levels are reduced and low-
density lipoprotein cholesterol (LDL-C) levels are increased in
hypothyroidism. The ratio between LDL-Cand HDL-C is high
in hypothyroid and normal in hyperthyroid patients. It was
reduced during thyroxine therapy in patients with
hypothyroidism but showed little change in patients with
hyperthyroidism.
The accelerated atherosclerosis in patients with
hypothyroidism is therefore related not only to the elevated total
cholesterol level but also to the low level of HD L-C. According
to Steinberg lO ischaemic heart disease is more prevalent among
hypothyroid patients when hypertension is present. It is
interesting to note that angina improves in some patients when
thyroxine therapy is staned even though oxygen requirements
are increased by thyroid hormone. 7 However, most patients
develop angina pectoris when treatment with thyroxine is
started. This form of angina is also dependent on the amount of
thyroid hormone the patient is receiving. In this group of
patients an anatomical narrowing of the coronary vessels seems
to be the logical explanation.
Schoolmeester and Jackman ll described a case in which they
thought coronary artery spasm caused angina. A hypothyroid
patient developed electrocardiographic features of coronary
artery spasm (ST elevation) during pain after treatment with
propranolol (a non-cardioselective R-blocker). Their explanation
is that both hypothyroidism and propranolol increase a-
adrenergic tone. This is accompanied by raised levels of
noradrenaline (primarily an a-adrenergic stimulant) in
hypothyroidism. This raised a-adrenergic tone potentiated by
the use of a non-cardioselective R-blocker may cause spasm.
Although this is a single case, one should bear it in mind when
prescribing R-blockers to patients with hypothyroidism.
Electrocardiographic features
The typical ECGofa patient with hypothyroidism exhibits sinus
bradycardia, small complexes and inverted or flanened T waves.
The small complexes have been attributed to an accompanying
pericardial effusion, but in the study of Kerber and Sherman6
small complexes were seen in only 5 of the 10 patients with and
even in some of the patients without pericardial effusion. It has
been stated that changes occur in patients after aspiration of the
pericardial fluid. We have only seen this phenomonen in the
patient who had tamponade. Conduction abnormalities such as
first-degree heart block may be present but are uncommon.
Pharmacokinetics of drugs
The kinetics of most drugs are affected by hypothyroidism. An
excellent review on this subject has been provided by
Shenfield. 12 The metabolism of thyroxine changes, with an
increase in half-life from 6 -7 to 9 - 10 days. The half-life of free
tri-iodothyronine (T,) is also prolonged, as is that of propranolol,
the dosage of which must therefore be reduced. Reduced hepatic
blood flow (part of the low-output syndrome) produces this
effect. Digitalis is often prescribed (whether correctly or not) for
hypothyroid patients because of their symptoms. These patients
are sensitive to the effects of digitalis and toxicity develops more
readily. There is a reduction in the Na' K'-ATPase and thus less
digitalis is needed to inhibit this enzyme. The dosage of oral
anticoagulants must be increased in hypothyroidism owing to an
increase in the half-life of clotting factors 11, VII, IX and X.
These are the more common drugs used in patients with
hypothyroidism. It is obvious that most drugs can be influenced
by this condition.
Treatment
Treatment of the hypothyroid patient with heart disease must be
individually tailored. Even though signs and symptoms may lead
to suspicion of heart failure, it must be kept in mind that heart
failure is an uncommon complication of hypothyroidism per se.
When digitalis is prescribed, the patient must be carefully
monitored for toxic side-effects. We have seen I patient who
developed total atrioventricular heart block after
commencement of digitalis therapy and in whom blood digitalis
levels were in the therapeutic range. Reduction of the digitalis
dosage overcame this problem. This patient focused our
attention on the doubtful value of 'therapeutic' blood levels of
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drugs in such patients. L-thyroxine is generally recommended
instead ofT, for substitution therapy. 13 Patients must be started
on a low dosage (25 j1g/d), which can be increased every 2 weeks
up to an appropriate dosage (0,1-0,15 mg/d). Heart failure may
be precipitated in some patients by commencing with too high a
dosage. 8 Thyroid status should be evaluated by determination of
serum thyroid-stimulating hormone levels, which normalize
when replacement is adequate.
Some patients will develop angina pectoris when substitution
therapy is started. IJ Propranolol has been used with varying
degrees of success in this group.14 Keeping the problem ofspasm
in mind, it might be wise to consider using a selective RI-blocker
such as meroprolol or atenolol. Even when R-blocking agents are
used it will be impossible to achieve normal thyroid hormone·
values in certain patients because of their angina. lit rates may
be of value and coronary btpass surgery has been successfully
performed in such patients. 4.15 Hay er al. 16 point out the dangers
of trying to render a hypothyroid patient with incapacitating
angina euthyroid. They recommend that determination of the
need for and time of operation is more important than attaining
normal thyroid hormone values pre-operatively. Patients can be
operated on safely whether or not they have received previous
thyroid hormone replacement therapy.
Pericardial effusion is rarely the cause of any haemodynamic
impairment and aspiration is usually unneces ary. Any other
cause contributing to the heart disease, such as anaemia or
hypertension, must be treated as required.
Conclusion
ewer methods of evaluation such as echocardiography and
coronary angiography aid in the evaluation and treatment of
hypothyroid patients. The alterations in drug pharmacokinetics
in hypothyroid patients must be kept in mind when prescribing
drugs for them. Most patients can be treated effectively with
relief of their cardiac symptoms as well as those caused by
abnormal thyroid hormone levels.
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